Imipenem And Cilastatin has 8 known drug interactions based on U.S. FDA drug labeling data. Of these, 4 are contraindicated combinations that should be avoided entirely. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Ganciclovir, Ganciclovir Sodium, Valganciclovir. Patients taking Imipenem And Cilastatin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 8
- Contraindicated
- 4
- Major
- 3
Contraindicated (4)
- Imipenem And Cilastatin + Ganciclovir— Generalized seizures reported with coadministration. Concomitant use not recommended unless potential benefits outweigh …
- Imipenem And Cilastatin + Ganciclovir Sodium— Generalized seizures have been reported in patients receiving ganciclovir and imipenem-cilastatin. Coadministration is n…
- Imipenem And Cilastatin + Valganciclovir— Generalized seizures have been reported in patients receiving ganciclovir and imipenem-cilastatin. Coadministration is n…
- Imipenem And Cilastatin + Valganciclovir Hydrochloride— Generalized seizures have been reported in patients receiving ganciclovir and imipenem-cilastatin. Coadministration is n…
Major (3)
- Imipenem And Cilastatin + Divalproex Sodium— Co-administration reduces divalproex sodium concentrations below therapeutic range, increasing risk of breakthrough seiz…
- Imipenem And Cilastatin + Probenecid— Concomitant administration increases plasma level and half-life of imipenem. Concomitant use is not recommended.
- Imipenem And Cilastatin + Valproic Acid— Co-administration reduces valproic acid concentrations below therapeutic range, increasing risk of breakthrough seizures…